Position in SCYX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,207,760
-$226,792 QoQ
Shares Held
296,747
+51.7% QoQ
Ownership
2.98%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 39 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCYX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VANGUARD CAPITAL MANAGEMENT LLC holds $8,313,887,454 across 56 Drug Manufacturers - Specialty & Generic names. SCYX ranks #44 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
26,027,984 | $1,870,370,930 | |
| 2 | VTRS |
Viatris Inc
|
76,046,939 | $1,207,625,391 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,918,256 | $1,039,368,648 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
4,545,339 | $766,071,435 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
22,607,532 | $556,371,362 | |
| 6 | ALKS |
Alkermes plc.
|
7,515,025 | $393,787,310 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
9,541,384 | $330,799,783 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
2,932,214 | $325,299,821 |
All Filings in SCYX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,207,760 | 296,747 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,434,552 | 1,564,398 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||